New genetic marker found to predict severe gout drug reactions in US patients

According to research recently published in JAMA Dermatology by Elizabeth Phillips, MD, and colleagues, a newly identified genetic marker, HLA-A*34:02, may significantly improve the ability to predict life-threatening reactions to the gout medication allopurinol in U.S. patients.